5 insider filings
Daniel Karlin, insider filing for DFTX
Show all 5
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Daniel Karlin, reporting
DFTX
Definium Therapeutics, Inc. SEC filings
Every EDGAR filing for Definium Therapeutics, Inc. (DFTX), newest first, with AI summaries and stories.
- Ticker
- DFTX
- CIK
- 1813814
- Latest filing
- Sep 29
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 5 open-market sales ($2.3M).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Definium Therapeutics, Inc.DFTXLIVE ROUTINE144Definium Therapeutics, Inc.DFTXLIVE 5 Form 144 notices
Mark Sullivan, planned sale of DFTX shares
Show all 5
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
Mark Sullivan, reporting
ROUTINE4Definium Therapeutics, Inc.DFTXLIVE 2 insider filings
Carol A Vallone, insider filing for DFTX
Show all 2
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Carol A Vallone, reporting
ROUTINE4Definium Therapeutics, Inc.DFTXLIVE 5 insider filings
Matthew T. Wiley, insider filing for DFTX
Show all 5
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Matthew T. Wiley, reporting
ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE ROUTINE4Definium Therapeutics, Inc.DFTXLIVE Robert Barrow, insider filing for DFTX
Robert Barrow, reporting
ROUTINE144Definium Therapeutics, Inc.DFTXLIVE Robert Barrow, planned sale of DFTX shares
Robert Barrow, reporting
ROUTINESCHEDULE 13G/ADefinium Therapeutics, Inc.DFTXLIVE Ownership stake disclosure by Commodore Capital LP (amended)
Commodore Capital LP, filed by
ROUTINESCHEDULE 13G/ADefinium Therapeutics, Inc.DFTXLIVE Ownership stake disclosure by DRIEHAUS CAPITAL MANAGEMENT LLC (amended)
DRIEHAUS CAPITAL MANAGEMENT LLC, filed by
ROUTINE4Definium Therapeutics, Inc.DFTXLIVE 5 insider filings
Brandi Roberts, insider filing for DFTX
Show all 5
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Brandi Roberts, reporting
ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE NOTABLE10-QDefinium Therapeutics, Inc.DFTXLIVE ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE ROUTINE4Definium Therapeutics, Inc.DFTXLIVE 5 insider filings
Matthew T. Wiley, insider filing for DFTX
Show all 5
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Matthew T. Wiley, reporting
ROUTINE144Definium Therapeutics, Inc.DFTXLIVE 5 Form 144 notices
Mark Sullivan, planned sale of DFTX shares
Show all 5
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
- 144Planned insider sale of DFTX shares
Mark Sullivan, reporting
ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE ROUTINE424B5Definium Therapeutics, Inc.DFTXLIVE ROUTINE424B5Definium Therapeutics, Inc.DFTXLIVE ROUTINE4Definium Therapeutics, Inc.DFTXLIVE 5 insider filings
Daniel Karlin, insider filing for DFTX
Show all 5
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
- 4Insider filing for DFTX
Daniel Karlin, reporting
ROUTINE8-KDefinium Therapeutics, Inc.DFTXLIVE